Literature DB >> 151126

Platelet monoamine oxidase activity in Huntington's chorea.

J Mann, E Chiu.   

Abstract

The possibility that genetically determined abnormalities in the monoamine oxidase of certain central nervous system aminergic neurones may play a part in the pathology of Huntington's chorea was investigated using human platelet monoamine oxidase. Significantly elevated monoamine oxidase activity was found in male patients compared to control subjects suggesting this may be a screening test for this disorder. Low monoamine oxidase activity was associated with a better clinical response to drugs.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 151126      PMCID： PMC493159          DOI： 10.1136/jnnp.41.9.809

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  16 in total

1.  GABA content and glutamic acid decarboxylase activity in brain of Huntington's chorea patients and control subjects.

Authors:  N Urquhart; T L Perry; S Hansen; J Kennedy
Journal:  J Neurochem       Date:  1975-05       Impact factor: 5.372

2.  Monoamine oxidase activity in blood platelets from patients with cyclophrenic depressive syndromes.

Authors:  J Landowski; W Lysiak; S Angielski
Journal:  Biochem Med       Date:  1975-12

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.

Authors:  P L McGeer; E G McGeer
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

5.  Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls.

Authors:  A Nies; D S Robinson; L S Harris; K R Lamborn
Journal:  Adv Biochem Psychopharmacol       Date:  1974

6.  Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea.

Authors:  E D Bird; A V Mackay; C N Rayner; L L Iversen
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

7.  Analysis of glutamate decarboxylase in post-mortem brain tissue in Huntington's chorea.

Authors:  L L Iversen; E D Bird; A V Mackay; C N Rayner
Journal:  J Psychiatr Res       Date:  1974       Impact factor: 4.791

8.  Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.

Authors:  E D Bird; L L Iversen
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

9.  Increased human platelet monoamine oxidase activity during lithium carbonate therapy.

Authors:  J Bockar; R Roth; G Heninger
Journal:  Life Sci       Date:  1974-12-15       Impact factor: 5.037

10.  Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.

Authors:  J Hughes
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739
View more
  10 in total

1.  Platelet phenolsulphotransferase activity, monoamine oxidase activity and peripheral-type benzodiazepine binding in demented patients.

Authors:  P Bongioanni; M Donato; M Castagna; F Gemignani
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 2.  The current state of research with peripheral tissues in Huntington disease.

Authors:  G C Beverstock
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 3.  Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.

Authors:  Marco Bortolato; Jean C Shih
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

4.  Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia.

Authors:  B Regland; C G Gottfries; L Oreland
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

5.  Abnormal platelet aggregation response in Huntington's disease.

Authors:  Y Muramatsu; H Kaiya; H Imai; M Nozaki; H Fujimura; M Namba
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

Review 6.  Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications.

Authors:  Ana I Casas; V Thao-Vi Dao; Andreas Daiber; Ghassan J Maghzal; Fabio Di Lisa; Nina Kaludercic; Sonia Leach; Antonio Cuadrado; Vincent Jaquet; Tamara Seredenina; Karl H Krause; Manuela G López; Roland Stocker; Pietro Ghezzi; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2015-11-10       Impact factor: 8.401

Review 7.  Human platelet monoamine oxidase activity in health and disease: a review.

Authors:  M Sandler; M A Reveley; V Glover
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

8.  Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls.

Authors:  J J Mann; R D Kaplan; E D Bird
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

9.  Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease.

Authors:  Jolene Ooi; Michael R Hayden; Mahmoud A Pouladi
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

Review 10.  Platelets in Neurodegenerative Conditions-Friend or Foe?

Authors:  Odette Leiter; Tara L Walker
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.